Jupiter scleral lenses in the management of chronic graft versus host disease.

Muriel M. Schornack, Keith Baratz, Sanjay V. Patel, Leo J. Maguire

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

OBJECTIVES: To describe the use of the Jupiter scleral contact lens (Medlens Innovations, Front Royal, VA or Essilor Contact Lens, Inc., Dallas, TX) in the management of ocular manifestations of chronic graft versus host disease (cGVHD). METHODS: This study is a retrospective case series. Five consecutive patients with severe keratoconjunctivitis sicca (KCS) associated with cGVHD that could not be adequately managed with conventional therapy were evaluated for scleral contact lens wear between January and December 2007. All patients were evaluated with lenses from the standard 18.2 mm Jupiter B diagnostic fitting set. If lenses of standard design failed to provide adequate fit, custom lenses were designed. Three outcome measures were evaluated: the patient's ability to tolerate and successfully handle the lenses, improvement in symptoms of KCS, and improvement in visual acuity. RESULTS: All 5 patients (10 eyes) were successfully fit with Jupiter scleral lenses. Six eyes of 3 patients were successfully fit with lenses of standard design. Standard parameters were altered to achieve adequate fit in 4 eyes of 2 patients. All patients reported subjective improvements in comfort with Jupiter scleral lenses, and best-corrected vision improved in 7 of the 10 eyes fit within the first several months of contact lens wear. The remaining 3 eyes maintained the visual acuity measured before scleral lens wear (20/20 in 2 eyes, 20/40 in 1 eye). Duration of follow-up ranged from 4 to 14 months. CONCLUSIONS: Jupiter scleral lenses can relieve symptoms of KCS and may improve vision in patients with cGVHD.

Original languageEnglish (US)
Pages (from-to)302-305
Number of pages4
JournalEye & contact lens
Volume34
Issue number6
StatePublished - Nov 2008

Fingerprint

Graft vs Host Disease
Lenses
Contact Lenses
Keratoconjunctivitis Sicca
Visual Acuity
Eye Manifestations
Aptitude
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schornack, M. M., Baratz, K., Patel, S. V., & Maguire, L. J. (2008). Jupiter scleral lenses in the management of chronic graft versus host disease. Eye & contact lens, 34(6), 302-305.

Jupiter scleral lenses in the management of chronic graft versus host disease. / Schornack, Muriel M.; Baratz, Keith; Patel, Sanjay V.; Maguire, Leo J.

In: Eye & contact lens, Vol. 34, No. 6, 11.2008, p. 302-305.

Research output: Contribution to journalArticle

Schornack, MM, Baratz, K, Patel, SV & Maguire, LJ 2008, 'Jupiter scleral lenses in the management of chronic graft versus host disease.', Eye & contact lens, vol. 34, no. 6, pp. 302-305.
Schornack, Muriel M. ; Baratz, Keith ; Patel, Sanjay V. ; Maguire, Leo J. / Jupiter scleral lenses in the management of chronic graft versus host disease. In: Eye & contact lens. 2008 ; Vol. 34, No. 6. pp. 302-305.
@article{43c7d60826404fe3ba49d136bdb2125d,
title = "Jupiter scleral lenses in the management of chronic graft versus host disease.",
abstract = "OBJECTIVES: To describe the use of the Jupiter scleral contact lens (Medlens Innovations, Front Royal, VA or Essilor Contact Lens, Inc., Dallas, TX) in the management of ocular manifestations of chronic graft versus host disease (cGVHD). METHODS: This study is a retrospective case series. Five consecutive patients with severe keratoconjunctivitis sicca (KCS) associated with cGVHD that could not be adequately managed with conventional therapy were evaluated for scleral contact lens wear between January and December 2007. All patients were evaluated with lenses from the standard 18.2 mm Jupiter B diagnostic fitting set. If lenses of standard design failed to provide adequate fit, custom lenses were designed. Three outcome measures were evaluated: the patient's ability to tolerate and successfully handle the lenses, improvement in symptoms of KCS, and improvement in visual acuity. RESULTS: All 5 patients (10 eyes) were successfully fit with Jupiter scleral lenses. Six eyes of 3 patients were successfully fit with lenses of standard design. Standard parameters were altered to achieve adequate fit in 4 eyes of 2 patients. All patients reported subjective improvements in comfort with Jupiter scleral lenses, and best-corrected vision improved in 7 of the 10 eyes fit within the first several months of contact lens wear. The remaining 3 eyes maintained the visual acuity measured before scleral lens wear (20/20 in 2 eyes, 20/40 in 1 eye). Duration of follow-up ranged from 4 to 14 months. CONCLUSIONS: Jupiter scleral lenses can relieve symptoms of KCS and may improve vision in patients with cGVHD.",
author = "Schornack, {Muriel M.} and Keith Baratz and Patel, {Sanjay V.} and Maguire, {Leo J.}",
year = "2008",
month = "11",
language = "English (US)",
volume = "34",
pages = "302--305",
journal = "Eye and Contact Lens",
issn = "1542-2321",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Jupiter scleral lenses in the management of chronic graft versus host disease.

AU - Schornack, Muriel M.

AU - Baratz, Keith

AU - Patel, Sanjay V.

AU - Maguire, Leo J.

PY - 2008/11

Y1 - 2008/11

N2 - OBJECTIVES: To describe the use of the Jupiter scleral contact lens (Medlens Innovations, Front Royal, VA or Essilor Contact Lens, Inc., Dallas, TX) in the management of ocular manifestations of chronic graft versus host disease (cGVHD). METHODS: This study is a retrospective case series. Five consecutive patients with severe keratoconjunctivitis sicca (KCS) associated with cGVHD that could not be adequately managed with conventional therapy were evaluated for scleral contact lens wear between January and December 2007. All patients were evaluated with lenses from the standard 18.2 mm Jupiter B diagnostic fitting set. If lenses of standard design failed to provide adequate fit, custom lenses were designed. Three outcome measures were evaluated: the patient's ability to tolerate and successfully handle the lenses, improvement in symptoms of KCS, and improvement in visual acuity. RESULTS: All 5 patients (10 eyes) were successfully fit with Jupiter scleral lenses. Six eyes of 3 patients were successfully fit with lenses of standard design. Standard parameters were altered to achieve adequate fit in 4 eyes of 2 patients. All patients reported subjective improvements in comfort with Jupiter scleral lenses, and best-corrected vision improved in 7 of the 10 eyes fit within the first several months of contact lens wear. The remaining 3 eyes maintained the visual acuity measured before scleral lens wear (20/20 in 2 eyes, 20/40 in 1 eye). Duration of follow-up ranged from 4 to 14 months. CONCLUSIONS: Jupiter scleral lenses can relieve symptoms of KCS and may improve vision in patients with cGVHD.

AB - OBJECTIVES: To describe the use of the Jupiter scleral contact lens (Medlens Innovations, Front Royal, VA or Essilor Contact Lens, Inc., Dallas, TX) in the management of ocular manifestations of chronic graft versus host disease (cGVHD). METHODS: This study is a retrospective case series. Five consecutive patients with severe keratoconjunctivitis sicca (KCS) associated with cGVHD that could not be adequately managed with conventional therapy were evaluated for scleral contact lens wear between January and December 2007. All patients were evaluated with lenses from the standard 18.2 mm Jupiter B diagnostic fitting set. If lenses of standard design failed to provide adequate fit, custom lenses were designed. Three outcome measures were evaluated: the patient's ability to tolerate and successfully handle the lenses, improvement in symptoms of KCS, and improvement in visual acuity. RESULTS: All 5 patients (10 eyes) were successfully fit with Jupiter scleral lenses. Six eyes of 3 patients were successfully fit with lenses of standard design. Standard parameters were altered to achieve adequate fit in 4 eyes of 2 patients. All patients reported subjective improvements in comfort with Jupiter scleral lenses, and best-corrected vision improved in 7 of the 10 eyes fit within the first several months of contact lens wear. The remaining 3 eyes maintained the visual acuity measured before scleral lens wear (20/20 in 2 eyes, 20/40 in 1 eye). Duration of follow-up ranged from 4 to 14 months. CONCLUSIONS: Jupiter scleral lenses can relieve symptoms of KCS and may improve vision in patients with cGVHD.

UR - http://www.scopus.com/inward/record.url?scp=58149314535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149314535&partnerID=8YFLogxK

M3 - Article

C2 - 18997537

AN - SCOPUS:58149314535

VL - 34

SP - 302

EP - 305

JO - Eye and Contact Lens

JF - Eye and Contact Lens

SN - 1542-2321

IS - 6

ER -